Pharm Tech Minutes 2021.02.05: Difference between revisions
Jump to navigation
Jump to search
Michael tan (talk | contribs) Created page with " Minutes = : Link to Microsoft Teams : [https://teams.microsoft.com/l/meetup-join/19%3ameeting_MzJkZmRhYTYtNmUyNi00YWJiLWEyOWUtMDI1Mjg2NWMzYzll%40thread.v2/0?context=%7b%22..." |
Michael tan (talk | contribs) |
||
| (5 intermediate revisions by the same user not shown) | |||
| Line 8: | Line 8: | ||
** Jose Costa Teixeira | ** Jose Costa Teixeira | ||
** Michael Tan | ** Michael Tan | ||
** Hans Lunenborg | |||
** Stephane Spahni | |||
** Leonidas Tzimis | |||
| Line 15: | Line 18: | ||
https://wiki.ihe.net/index.php/Pharm_Tech_Minutes_2021.01.08 | https://wiki.ihe.net/index.php/Pharm_Tech_Minutes_2021.01.08 | ||
== F2F == | |||
* Will organize a video conference instead of face to face meeting in March. | |||
* Settled on 2 afternoon's on 16 and 17 th of March | |||
* Organize 2 x 1,5 hour for each session | |||
* Michael will set up an initial proposal for the meetings | |||
* The schedule has been updated and can be found [https://docs.google.com/document/d/16dMTznXgqUO2IiEk6z-B8G-PFOte1Xav/edit# here]. | |||
== Documentation == | |||
* No consensus with John Moerkhe about the documentation method of IHE. | |||
* According to John their is no planning from IHE. | |||
* Who should make the decision. Topic for DCC? How do we manage the plan. | |||
* Jose to carry the topic to DCC. | |||
== Medication List == | |||
* HL7 Pharmacy is also running a topic called Active Medication lists. | |||
* Jose is working with Belgian insurance company about a medication list architecture. The information can be found here: | |||
http://build.fhir.org/ig/hl7-be/hl7-be-fhir-medication/branches/master/StructureDefinition-be-model-medication-record.html | |||
* No contact with Oliver Egger. Stephane to contact Oliver. | |||
== Vaccination == | |||
* Stephane mentioned that IHE Gemini already has a topic on inquiring a vaccination. See: | |||
https://www.ihe.net/news/ihe-continues-to-pave-the-way-for-fhir-through-project-gemini/ and http://blog.hl7.org/another_type_of_moonshotproject_gemini | |||
* Serious interest from DCC. Chris Carr arranged an interview with Carrie Pallardy with the purpose of recruiting other sponsors. | |||
* Looking for funding and interested parties. | |||
* Meanwhile the biweekly calls will carry on with modelling work on the content. | |||
== Any other business == | == Any other business == | ||
Latest revision as of 09:36, 5 February 2021
Minutes =
- Link to Microsoft Teams
- Teams
Welcome
- Participants
- Jose Costa Teixeira
- Michael Tan
- Hans Lunenborg
- Stephane Spahni
- Leonidas Tzimis
- Review and Approve Agenda
- Review minutes previous meetings:
https://wiki.ihe.net/index.php/Pharm_Tech_Minutes_2021.01.08
F2F
- Will organize a video conference instead of face to face meeting in March.
- Settled on 2 afternoon's on 16 and 17 th of March
- Organize 2 x 1,5 hour for each session
- Michael will set up an initial proposal for the meetings
- The schedule has been updated and can be found here.
Documentation
- No consensus with John Moerkhe about the documentation method of IHE.
- According to John their is no planning from IHE.
- Who should make the decision. Topic for DCC? How do we manage the plan.
- Jose to carry the topic to DCC.
Medication List
- HL7 Pharmacy is also running a topic called Active Medication lists.
- Jose is working with Belgian insurance company about a medication list architecture. The information can be found here:
- No contact with Oliver Egger. Stephane to contact Oliver.
Vaccination
- Stephane mentioned that IHE Gemini already has a topic on inquiring a vaccination. See:
https://www.ihe.net/news/ihe-continues-to-pave-the-way-for-fhir-through-project-gemini/ and http://blog.hl7.org/another_type_of_moonshotproject_gemini
- Serious interest from DCC. Chris Carr arranged an interview with Carrie Pallardy with the purpose of recruiting other sponsors.
- Looking for funding and interested parties.
- Meanwhile the biweekly calls will carry on with modelling work on the content.